RECEPTOR.AI

Receptor.ai develops an integral AI-based approach, which combines the best features of protein- and membrane-targeting compounds to create drugs with superior properties. Our AI algorithms are trained on extensive set of public and proprietary experimental data, clinical trials data and the results of in-house numerical simulations. The company's mission is to create superior drugs, which are safe, efficient and successful in clinical trials by developing a next-generation drug discovery platform based on the synergy of AI, computational chemistry and biomimetic technologies, such as organs-on-a-chip.